Posts filed under: Peripheral Vascular

Contego Medical Receives CE Mark For Vanguard IEP Peripheral Balloon Angioplasty System With Integrated Embolic Protection

Contego Medical, LLC recently announced that it has received CE Marking of its Vanguard IEP™ Peripheral Balloon Angioplasty System with Integrated Embolic Protection. ...
Continue Reading →

C.R. Bard, AngioDynamics Lead Competitive U.S. Implantable Port Market Driven by Increased Use in Cancer Treatments

The U.S. power-injectable implantable port market is expected to increase over the forecast period, driven predominantly by cancer treatments that require long-term vascular access....
Continue Reading →

The U.S. Peripheral Vascular Device Market: Shifting Demographics, Technological Innovation Fueling Growth

By Kamran Zamanian, Ph.D, and Sean Collins, iData Research Inc. Growth of the United States’ elderly population has driven a steady increase in the number of patients requiring treatment for peripheral vascular lesions. Meanwhile, the availability of increasingly sophisticated technology...
Continue Reading →

Sauna Use Could Reduce Risks of Cardiovascular Disease

A new study by the University of Eastern Finland claims that spending time at a sauna could reduce the risk of cardiovascular disease and other ailments....
Continue Reading →

Study Suggests that Drug-Eluting Stents are Safe and Effective

Clinical results from the Rabin Medical Center in Israel have showed a correlation between the use of drug-eluting stents and an improvement in long-term results for patients undergoing angioplasties....
Continue Reading →

Vascular Closure Devices to Drive U.S. Peripheral Vascular Device Market

In 2009, over 650,000 vascular closure devices (VCDs) were sold in the U.S. for use in peripheral vascular procedures, which accounted for approximately 20% of vascular closure devices used in all applications....
Continue Reading →

U.S. Peripheral Vascular Market to Exceed $5.3 Billion by 2016

Growth in the U.S. peripheral vascular device market, which was valued at $2.8 billion in 2009, will be primarily driven by increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD)....
Continue Reading →

Thank you!

CLOSE

Login

Sign Up

or Login

×